You will be the leader of your assigned territory in the commercialization of gedatolisib, poised to transform advanced breast cancer treatment with groundbreaking clinical data.
Base: $185,000-$215,000 DOE; Bonus/Equity: Annual performance incentive bonus and new hire equity package; Benefits: Medical, dental, vision insurance, 401(k) match, PTO, and paid holidays
Must-have
Nice-to-have
Not specified